Transcript NexGen / C2C Partnership

C2C
Medical Device Product Development
Overview

C2C is a medical device company focused on front end
product development and pilot production.

C2C partners with universities, physician inventors and
other device companies.

C2C provides product development services in exchange
for fee and/or equity based compensation.

C2C is also developing its own portfolio of devices for less
invasive surgery.
The C2C Advantage
EXPERIENCE: We have done this before
COMPETANCE: We do it for a living
DEDICATION: We love what we do
Examples of our Work
Neurological Drug Delivery
Concept
Commercialization
Brain Biopsy
Concept
Commercialization
Deep Brain Stimulation
Concept
Commercialization
Laser Atherectomy
Commercialization
Concept
Laparoscopic Suction Irrigator
Concept
Commercialization
SLA Prototypes
Robotic Neuro Trajectory Guide
Concept
Nationally Recognized
“Medical Design Excellence Award”
MD&DI magazine 2007
Implantable & Device Categories
Cover article “Journal of Neurosurgery”
September 2005
C2C Development, LLC
FOUNDERS
Matthew S. Solar P.E.
•
20 years Medical Device R&D
•
Over 40 issued patents
Craig Pagan
•
20 years Medical Device Operation
•
GMP/ISO quality systems
Glenn Perry
•
25 years Manufacturing
C2C Capabilities












3D Solid Modeling
Rapid Prototyping
Pilot Production
Heat Treating
UV Bonding
Soldering
Coil Winding
Packaging
Sterilization
Validated Parts Cleaning
Class 100,000 Clean Room
cGMP/ISO Compliant Quality System
Current Partners

NexGen Medical Systems, Inc.


Engineering Resources Group / Therataxis


Intraparenchymal drug delivery
Monteris Medical


Thrombectomy device
MRI guided Laser ablation
Medtronic Neuromodulation

Manufacturing
Conclusion
C2C is a medical Device company with an experienced
management team seeking development partners and
advisory board members.
Contact:
C2C
Matt Solar/Craig Pagan
1050 NASA Blvd. Ste 136
Melbourne, FL 32901
(321) 729-0125